Kura Oncology (KURA)
Healthcare · Biotechnology
1 member of Congress has disclosed 1 trade in Kura Oncology (KURA) since 2022: 1 buy and 0 sales. The most recent was disclosed on Jan 20, 2023.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 1 / 0
- Reported value
- $1K–$15K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at KURA
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded KURA
- Rep. Chris Jacobs (R-NY-27)1 buy · 0 sales10Jan 20, 2023
All trades
- Jan 20, 2023$1K–$15K
Rep. Chris Jacobs (R-NY-27)
$1K–$15K · Traded Dec 12, 2022 · disclosed Jan 20, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.